GENEVA, Oct. 26 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, Gongshu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/089047) for "ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 2B AND USE THEREOF" on Apr 15, 2025. With publication no. WO/2025/218662, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...